text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 112809-51-5 | Product Number: L0248

Letrozole


Purity: >98.0%(T)(HPLC)
Synonyms:
  • 1-Bis(4-cyanophenyl)methyl-1,2,4-triazole
  • 4,4'-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile
Product Documents:
1G
£90.00
6   ≥100 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number L0248
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__7H__1__1N__5 = 285.31 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Condition to Avoid Heat Sensitive
CAS RN 112809-51-5
Reaxys Registry Number 6813913
PubChem Substance ID 172089003
Merck Index (14) 5450
MDL Number

MFCD00866241

Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Melting point 183.0 to 187.0 °C
Properties (reference)
Melting Point 185 °C
Solubility in water Insoluble
Solubility (slightly sol. in) Methanol
GHS
Pictogram Pictogram Pictogram
Signal Word Danger
Hazard Statements H302 + H312 + H332 : Harmful if swallowed, in contact with skin or if inhaled.
H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
H360 : May damage fertility or the unborn child.
H362 : May cause harm to breast-fed children.
Precautionary Statements P263 : Avoid contact during pregnancy and while nursing.
P260 : Do not breathe dust.
P202 : Do not handle until all safety precautions have been read and understood.
P201 : Obtain special instructions before use.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
Related Laws:
RTECS# DI4957000
Transport Information:
HS Number 2933998090
Application
Letrozole: A Nonsteroidal, Potent and Selective Aromatase Inhibitor

Letrozole (CGS 20267), exemestane [E0941] and anastrozole [A2370] are third generation, and potent and selective aromatase inhibitors. In postmenopausal women, estrogens are mainly derived from the action of the aromatase which is responsible enzyme for the aromatization of androgens ([A0845] and [T0027]) into estrogens ([E0026] and [E0025]) respectively in the periphery. The growth of the breast cancer is stimulated or maintained by estrogens. Letrozole, exemestane and anastrozole inhibit aromatase and estrogen synthesis, resulting in suppressing tumor growth. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.